ScandiDos AB (publ) (SDOS.ST) Research

ScandiDos AB (publ), established in Uppsala, Sweden, in 2005, develops advanced measurement systems and software specifically for the quality assurance (QA) and validation demands of innovative medical treatments utilized in clinics worldwide. Their flagship Delta4 Family solution offers comprehensive dose verification, both before and during treatment, across a wide array of radiation therapy techniques, including VMAT, IMRT, SBRT, 4D-RT, and TomoTherapy. The Delta4 Discover is a transmission detector providing real-time measurements to bolster confidence and patient safety. Additionally, the Delta4 Phantom+ system ensures accurate verification of IMRT, VMAT, and TomoTherapy plans. The company's product line also includes HexaMotion, a dedicated solution for motion management. Their software offerings comprise Delta4DVH Anatomy, which verifies and analyzes the administered dose within a patient's anatomical structures, and Delta4 Machine QA, designed for conducting quality checks on machine rotation, start-up performance, and dynamic beam modulation.

Market snapshot

Symbol
SDOS.ST
Price
$0.84
Day change
+0.60%
Market cap
$47.9M
P/E ratio
-13.93x
52-week range
0.81-1.495
Sector
Healthcare
Industry
Medical - Devices

Peer companies

  • AcouSort AB (publ) (ACOU.ST)
  • Scandinavian Real Heart AB (Publ) (HEART.ST)
  • Kontigo Care AB (publ) (KONT.ST)
  • Lipigon Pharmaceuticals AB (publ) (LPGO.ST)
  • Newbury Pharmaceuticals AB (publ) (NEWBRY.ST)
  • OncoZenge AB (publ) (ONCOZ.ST)
  • Ortivus AB (publ) (ORTI-B.ST)
  • Simris Alg AB (publ) (SIMRIS-B.ST)

Open ScandiDos AB (publ) (SDOS.ST) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.